Expanding Recombinant Tissue Plasminogen Activator Time Window Is Premature
نویسندگان
چکیده
منابع مشابه
Expanding recombinant tissue plasminogen activator time window is premature.
Stroke welcomes Letters to the Editor and will publish them, if suitable, as space permits. They should not exceed 750 words (including references) and may be subject to editing or abridgment. Please submit letters in duplicate, typed double-spaced. Include a fax number for the corresponding author and a completed copyright transfer agreement form (available online at http://stroke.ahajournals....
متن کامل4.5-hour time window for intravenous thrombolysis with recombinant tissue-type plasminogen activator is established firmly.
This is a clear case. Yes! The patient should immediately be treated with the standard dose of rt-PA as per approval in Europe and many other countries on this planet. After the results of all pooled analyses (National Institute of Neurological Disorders and Stroke [NINDS], European Cooperative Acute Stroke Study 1–2 [ECASS 1–2], Alteplase Thrombolysis for Acute Noninterventional Therapy in Isc...
متن کاملOptimizing refolding condition for recombinant tissue plasminogen activator
Low molecular size additives such as L-arginine and the redox compounds have been used both in the culturemedium and in vitro refolding to increase recombinant proteins production. Additives increase proteinrefolding and yield of active proteins by suppressing aggregate formation or enhancing refolding process.In this work, a comparative study was performed on refolding of rec...
متن کاملThe New Time Window for Tissue Plasminogen Activator in Stroke
The publication of the National Institute of Neurological Diseases and Stroke trial 13 years ago was one of the most exciting events in modern stroke medicine, demonstrating the powerful effect of tissue plasminogen activator (tPA) in acute ischemic stroke within 3 hours of symptom onset.1 The sound barrier for stroke treatment had been broken. The European Cooperative Acute Stroke Study III (E...
متن کاملThe Outcome of Treatment With Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
Background: Thrombolytic therapy is the recommended treatment of acute ischemic stroke. It is crucial to evaluate the treatment results with recombinant Tissue Plasminogen Activator (r-TPA) in patients with acute stroke. Objectives: This study aimed to evaluate treatment outcomes with r-TPA in patients with acute stroke in a referral stroke center in Iran. Materials & Methods: In this retrosp...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Stroke
سال: 2009
ISSN: 0039-2499,1524-4628
DOI: 10.1161/strokeaha.109.560615